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Biochemical evidence is vital for accurate genome annotation. The integration of
experimental data collected at the proteome level using high resolution mass
spectrometry allows for improvements in genome annotation by providing evidence for
novel gene models, while validating or modifying others. Here, we report the results of
a proteogenomic analysis of a reference strain of Mycobacterium smegmatis (mc2155),
a fast growing model organism for the pathogenic Mycobacterium tuberculosis—the
causative agent for Tuberculosis. By integrating high throughput LC/MS/MS proteomic
data with genomic six frame translation and ab initio gene prediction databases, a total
of 2887 ORFs were identified, including 2810 ORFs annotated to a Reference protein,
and 63 ORFs not previously annotated to a Reference protein. Further, the translational
start site (TSS) was validated for 558 Reference proteome gene models, while upstream
translational evidence was identified for 81. In addition, N-terminus derived peptide
identifications allowed for downstream TSS modification of a further 24 gene models.
We validated the existence of six previously described interrupted coding sequences at
the peptide level, and provide evidence for four novel frameshift positions. Analysis of
peptide posterior error probability (PEP) scores indicates high-confidence novel peptide
identifications and shows that the genome of M. smegmatis mc2155 is not yet fully
annotated. Data are available via ProteomeXchange with identifier PXD003500.
Keywords: Mycobacterium smegmatis mc2155, mass spectrometry, proteogenomics, genome annotation,
proteomics
INTRODUCTION
Evidence for the existence of protein coding genes include ab initio gene predictions, transcriptomic
analysis, and comparative genomics information (Krug et al., 2011). Although, gene annotation of
model organisms often relies on transcript sequencing, it has become apparent that evidence of
transcription may not equal evidence of translation (Castellana and Bafna, 2010). Proteomics data,
on the other hand, gives direct evidence of which genes are translated. Using proteomics data, true
genes can be separated from pseudogenes, and the translational frame can be determined. The
location of TSSs (translational start sites) can be identified, while signal cleavage and other post-
translational modifications (PTMs) can be identified (Kucharova andWiker, 2014). By mapping to
uncharacterized genomic coordinates, novel genes can be identified (Borchert et al., 2010).
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Genomic six frame translation allows for the creation of
a database containing, in the ideal case, all possible putative
proteins, but at the cost of including many spurious entries.
This leads to decreased sensitivity of identifications at the same
FDR as standard proteomic databases with a higher proportion
of non-spurious entries (Castellana and Bafna, 2010). Due
to the large database sizes involved in proteogenomics, and
large numbers of spectra that need to be assigned, many false
positive identifications are obtained even at a low error rate.
To limit the number of spurious entries, thus increasing the
sensitivity of identifications, proteogenomic databases can be
compacted, by excluding entries below a minimum length cutoff
or only focusing on genomic regions identified by ab initio gene
prediction tools (Castellana and Bafna, 2010).
Automated gene prediction at the early stage of genome
annotation is prone to errors, with rates of incorrect TSS
prediction of up to 44% reported (Gallien et al., 2009), while
short protein-coding genes are difficult to predict (Renuse et al.,
2011). Accurately identifying the TSS of a gene is complicated by
the existence of different possible start codons, with many non-
standard start codons identified in prokaryotes (Castellana and
Bafna, 2010). Mycobacteria are known to use GTG and TTG as
initiator Met (fMet) start codons, in addition to translation of
these codons with Val and Leu, respectively (Kelkar et al., 2011).
Wang et al. (2005) used databases of gene predictions to
identify mass spectra, identifying 901 proteins inMycobacterium
smegmatis using the partially sequenced genome available at
the time—validating many predicted genes. Gallien et al. (2009)
identified 946 proteins in M. smegmatis, characterizing 443 N-
terminal peptides, and revealed an error rate of 19% in predicted
TSSs. Kelkar et al. (2011) reported 41 novel protein-coding genes
in Mycobacterium tuberculosis strain H37Rv. By identifying N-
terminal peptides, the authors were able to correct the TSS of
33 proteins, and validate the TSS of 727 annotated proteins.
Strikingly, the authors identified eight proteins with evidence for
translation initiation at two different sites.
The occurrence of false positive peptide identifications
from tandem mass spectrometry data implies the need for
statistical concepts such as the false discovery rate (FDR) and
posterior error probability (PEP) score to gauge the reliability
of identifications. The FDR is controlled by scoring and ranking
peptide spectral matches (PSMs), and identifying the score
above which a maximum allowable proportion of PSMs from a
decoy database are identified—indicating the expectedmaximum
proportion of incorrect PSMs—while posterior error probability
(PEP) indicates the probability of error of a single PSM (Käll et al.,
2008). The MaxQuant algorithms calculate PEP scores based on
search engine PSM scores and peptide length, and determine a
cutoff PEP score at a specific FDR (Cox and Mann, 2008).
Krug et al. (2013) compared the number and median PEP
scores of novel peptide identifications with reverse sequence hit
peptides in a proteogenomic analysis of Escherichia coli, and
determined that the absolute number as well as the median
PEP-values for both groups were very similar. The authors
concluded that as a genome approaches complete annotation,
the likelihood of any novel peptide identification being a false
positive identification increases (Krug et al., 2013).
Annotation of coding regions for organisms is a continuously
evolving process. The genome of M. tuberculosis was sequenced
in 1998 (Cole et al., 1998), yet a few years later, the same authors
re-annotated the genome and identified 71 more ORFs than
before (Camus et al., 2002). To date, the M. tuberculosis genome
is annotated with 4018 ORFs1. This highlights the importance of
continuous review and re-annotation of genomes as technologies
improve. TheM. smegmatismc2155 genome may not yet be fully
annotated, and the genome sequence has been shown to contain
multiple errors (Deshayes et al., 2007), one of the reasons being
the high GC content and genome annotation shortfalls, such as
short protein validation and incorrect TSS assignment of genes.
That poses a problem by limiting our understanding of the many
cellular processes coded by these genes. It is imperative that the
genome of M. smegmatis mc2155 be fully annotated since this
bacterium, due to its non-pathogenic and fast growing status,
is used frequently as a model organism to study the biology of
M. tuberculosis, the causative agent of Tuberculosis. Tuberculosis
continues to be a burden on the health system, with an estimated
9.6 million cases of infection and 1.5 million deaths in 2014,
despite a globally decreasing incidence of∼1.5% every year since
2000 (WHO, 2015). Limited understanding of the biology of M.
tuberculosis is an obstacle to improving current treatment and
eradication of the disease. Thus, it is hoped that refinements in
proteogenomics pipelines and the study of model organisms of
M. tuberculosis such as M. smegmatis mc2155, may further our
understanding of this pathogenic organism.
In this study, we developed and applied a compacted six frame
genomic database, to map high resolution and high accuracy
tandem mass spectrometry coupled to liquid chromatography
data to re-evaluate the genome annotation of M. smegmatis
mc2155. We also used a database of ab initio gene predictions
using GeneMarkS2 in the proteogenomics pipeline to identify
novel open reading frames, gene model validations, and gene
model modifications. By analyzing the PEP score distribution of
novel, annotated, and reverse sequence hit peptides, we explored
the current annotation status ofM. smegmatismc2155.
MATERIALS AND METHODS
Bacterial Cultures
Wild type strain of M. smegmatis mc2155 were grown in 7H9
Middlebrook (BD, Maryland, USA) broth supplemented with
0.05% Tween 80, OADC (Becton Dickinson), and 0.2% glycerol
(v/v). Cells were grown at 37◦C with continuous agitation
(120 rpm).
Protein Extraction
Cells were harvested from three biological replicates each during
the exponential and early stationary phase (OD600 ∼ 1.2 and 1.8,
respectively) by centrifugation at 4000 g for 15 min at 4◦C. Cell
pellets were washed with PBS (10mM phosphate buffer, 2.7mM
potassium chloride, and 137mM sodium chloride, pH 7.4) and
flash frozen in liquid nitrogen and stored at −80◦C. Pellets were
1http://tuberculist.epfl.ch/
2GeneMarkTM—Free Gene Prediction Software.” http://exon.gatech.edu/Gene
Mark/(Accessed September 21, 2015).
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suspended in lysis buffer [500mM Tris-HCl, 0.1% (w/v) SDS,
0.15% sodium deoxycholate], 1× protease inhibitor cocktail, 1×
phosphatase inhibitor cocktail (Roche, Mannheim Germany),
and 50 µg/ml lysozyme (Repaske, 1956) and disrupted by
sonication at maximum power for six cycles of 30 s, with
1 min cooling on ice between cycles (Rezwan et al., 2007).
Lysates were further clarified using centrifugation at 4000 g for
5 min and filtering through a 20 µm pore size low-protein
binding filter (Merck, NJ, USA). Proteins were precipitated using
the chloroform–methanol precipitation method as previously
described (Wessel and Flügge, 1984). Protein precipitate was
suspended in denaturing buffer (10mM Tris-HCl, 6M urea, 2M
thiourea, pH 8). Protein concentration was determined using the
modified Bradford assay as described by Ramagli (1999).
In-Solution Trypsin Digestion
Fifty micrograms of precipitated protein was reduced with 1mM
DTT for 1 h followed by another hour of incubation in the
presence of 5.5mM IAA. Alkylated protein samples were pre-
digested for 3 h at room temperature with lysyl endopeptidase
LysC (Waco, Neuss, Germany). Pre-digested samples were
diluted four-fold with 20mM ammonium bicarbonate pH 8 prior
to trypsination. Sequencing grade modified trypsin (Promega,
Madison, USA) was used at a protease:protein ratio of 1:50 (w/w)
for 14 h at room temperature with gentle agitation. Trypsination
was terminated with 0.1% formic acid final concentration
(Sigma Aldrich, St Louis, USA). Ten micrograms of peptides
were desalted using a homemade stage tip containing Empore
Octadecyl C18 solid-phase extraction disk (Supelco; Rappsilber
et al., 2003). Activation, equilibration, and peptide wash and
elution were all carried out using centrifugation at 5000 g for
5 min. Activation and equilibration of the C18 disk was carried
out using three rinses with 80% acetonitrile (ACN), followed by
three rinses with 2% ACN, respectively. Peptide rich solution was
loaded onto the disk and centrifuged. Desalting was carried out
using three washes of 2% ACN, followed by three washes of 2%
ACN containing 0.1% formic acid (Sigma). Elution of desalted
peptides into glass capillary tubes was carried out using three
rounds of 100 µL of 60% ACN, 0.1% formic acid. Peptides were
dried in a vacuum and resuspended in 2% ACN, 0.1% formic acid
at 50 ng/µL.
LC/MS/MS Analysis
Data acquisition was performed on the Orbitrap Q-Exactive
mass spectrometer (Thermo Scientific) in a data-dependent
manner, coupled to the Dionex Ultimate 3000 UHPLC (Thermo
Scientific). One microgram of peptides were loaded on to an
inhouse packed pre-column (100 µm ID × 20 mm) connected
to an in-house packed analytical column (75 µm × 400 mm)
both packed with C18 Luna 5 µm 100 Å beads (04A-5452) for
liquid chromatography separation. The flow rate was set to 300
nl/min with the gradient of 2% to 25% ACN for 125 min, then
up to 35% in 5 min. To wash the column ACN was increased to
80% for 20 min followed by a column equilibration at 2% ACN
for 10 min. A top 10 method with 30 s dynamic exclusion was
used to acquire mass spectra with automatic switching between
MS and MS/MS scans. The LC/MS/MS methods used have been
described previously (Nakedi et al., 2015).
Proteogenomic Databases
The genome of M. smegmatis mc2155 was accessed from
the European Nucleotide Archive under the accession number
CP000480, Genome Assembly GCA_000015005.1 (Fleischmann
et al., 2006). To facilitate genomic database compaction each
open reading frame in the six frames was translated in silico
starting at the most upstream start codon—using possible start
codons ATG, GTG, and TTG—and sequences below a minimum
translated length of 20 amino acids were excluded from the
database. For sequences at the end of each of the genomic frames
that did not end in a stop codon, the sequence up till the last
in-frame codon was translated and included in the database.
The genomic coordinates of the six frame translated sequences
were included in the FASTA headers of the database. Translated
sequences that occurred more than once in the database were
combined into a single entry with multiple genomic coordinates.
The Reference proteome for M. smegmatis mc2155 was obtained
from UniProt3 (Proteome ID UP000000757), and any translated
six frame sequence overlapping with or identical to a Reference
protein sequence was mapped to that protein in the FASTA
header.Where a Reference sequence was located downstream of a
translated six frame TSS, the number of amino acids difference in
the N-termini of the two sequences was recorded, and six frame
sequences identical to a protein in the Reference proteome were
labeled. Overlapping open reading frames were included in the
database, leading to a final database size of 79,481 entries.
A second genomic database for targeted identification of
TSSs was generated using ab initio prediction of protein-coding
genes with the GeneMarkS software package (version 4.28)—at
the same time providing supporting evidence for novel protein
identifications and gene model modifications. This software uses
a Hidden Markov Model algorithm, combined with models of
protein coding and non-coding regions and gene regulation sites,
to predict the occurrence of genes in a DNA sequence (Besemer
et al., 2001). The predicted genes were translated and the final
database contained 6655 sequences.
Database Search Using Maxquant
The MaxQuant software package (version 1.5.0.30) was used
to search the raw MS spectra using the Andromeda search
engine separately against the six frame database, UniProt
Reference proteome and GeneMarkS database—using reverse
decoy databases and a selection of known contaminants provided
by MaxQuant. Trypsin and LysC were selected as enzymes,
and a maximum of three missed cleavages were allowed.
Specific enzyme mode was selected, which allowed for the
detection of non-tryptic N-terminal peptides of database entries,
peptides with N-Met cleavage, and fully tryptic peptides.
Carbamidomethyl was set as a fixed modification and Acetyl
(Protein N-term) and Oxidation (M) were set as variable
modifications. A minimum peptide length of seven amino acids,
and a minimum of one unique peptide identification per protein
group, was required. The default MaxQuant false discovery
3UniProt. http://www.uniprot.org/ (Accessed September 21, 2015).
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rate (FDR) cutoff of 0.01 (1%) was used at the PSM, peptide
and protein group levels. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium
(Vizcaíno et al., 2014) via the PRIDE partner repository (Vizcaíno
et al., 2013) with the dataset identifier PXD003500 and the data is
freely available4.
Proteogenomic Analysis
We relied heavily on previously published proteogenomic
protocols, in particular the methodology described by Kelkar
et al. (2011)—differing in that we used a separate search database
(GeneMarkS) for targeted TSS identification, and did not exclude
all novel peptides mapping to multiple genomic locations,
allowing for the identification of paralogous translated ORF
sequences.
All MaxQuant results for the different databases were
combined using an in-house python script. Use was made
of the Biopython software package5 (Cock et al., 2009).
Pettersen et al. (2015) only considered proteins identified
in at least two replicates in their proteogenomic analysis of
enterotoxigenic Escherichia coli—similarly, we only considered
peptides identified in at least two replicates for further analysis.
All peptides were searched against the genome dynamically
translated in the six reading frames, and peptides unique to a
single position in the genome were identified. Mycobacteria are
known to have duplications in protein-coding genes due to the
effect of transposable elements (Dale, 1995). To allow for the
detection of paralogous sequences, peptides specific to a single
repeating translated six frame ORF sequence in the genome were
identified as paralogous sequence peptides, and also included in
the analysis, but identified as belonging to paralogous translated
ORF sequences.
Peptides not found in the Reference proteome were identified
as genome search specific peptides (GSSPs). GSSPs are peptides
mapping to genomic regions not considered to be coding regions,
or not included in overlapping or adjacent gene models (Kelkar
et al., 2011). We used the UniProt Reference proteome as
a benchmark for annotation status to discriminate annotated
peptides from GSSPs. Only GSSPs were used for upstream gene
model modifications and novel gene model identifications, while
N-terminal peptides mapping downstream in the gene model of
Reference proteins were used for downstream TSS assignment.
N-terminal peptides mapping to the start of Reference protein
gene models were used for TSS validation. All protein groups
with no peptides unique to the protein sequence after performing
the genome search, were excluded from further analysis. All
results in the different databases mapping to the same ORF were
identified for comparison, and the unique identified peptide set
across all three databases for eachORFwas obtained. All database
entries were mapped to their respective ORFs in the genome
using an in-house python script (see Figure 1).
TSS peptides were identified by the non-tryptic nature of
their N-terminals, N-Met cleavage, or N-terminal acetylation.
Reference protein start sites were validated by identifying TSS
4http://www.ebi.ac.uk/pride/archive/
5Biopython-Biopython. Available online at: http://biopython.org/wiki/Main_Page
(Accessed September 21, 2015).
peptides mapping to the genomic coordinates of the start of a
Reference protein sequence. All open reading frames mapping
to Reference proteins, with peptides identified upstream in the
ORF from the annotated TSS of the Reference protein, were
identified for upstream gene model modification, while N-
terminal peptides mapping downstream of a Reference protein
start were used for downstream gene model modification. The
coordinates of novel ORFs were compared to the coordinates
of known cDNA features (sequenced transcripts obtained from
Ensembl6 using a sense strand genome coordinate search (in-
house python script), andORFs overlapping with cDNA evidence
in the genome were identified. A nucleotide BLAST of novel
ORFs was performed against the transcript sequences, requiring
same strand alignment with an E-value cutoff of 0.0001. A protein
BLAST of novel translated ORFs, as well as ORFs for which
gene model modification were identified, was performed against
the NCBI non-redundant (nr) BLAST database, and the highest
scoring alignment by E-value was obtained for each sequence,
using an E-value cutoff of 0.0001. The leading gi IDs of protein
BLAST results were converted to UniProtKB IDs using the
UniProt Retrieve/ID Mapping tool. Novel ORFs were ranked
by number of identified GSSPs, protein BLAST evidence, cDNA
nucleotide BLAST evidence, and cDNA coordinate overlap.
Interrupted CoDing Sequences (ICDSs) are erroneously
shortened gene model predictions either due to the presence
of unrecognized true genomic events (such as programmed
frameshifts or in-frame stop codons), or artificially due to
sequencing errors (Perrodou et al., 2006). We followed the
methodology described by Perrodou et al. (2006) and Deshayes
et al. (2007) to identify ICDSs based on shared homologous
sequence evidence (protein BLAST) of adjacent or overlapping
non-paralogous ORFs, but differ in that we only focused onORFs
identified at the peptide level.
All peptides identified in the three databases in at least two
replicates, as well as the GeneMarkS FASTA database, were
processed into general feature format (GFF) files for visualization
using the Ensembl genome browser for this strain7—allowing
for manual examination of novel annotations, gene model
modifications, and ICDSs (see Supplementary Data Sheets 1–4).
The PEP score distributions of novel, annotated and reverse
peptide identifications from each database were analyzed with
in-house python and R scripts. Use was made of the python
module matplotlib (Hunter, 2007) to produce boxplots of the
PEP score distributions, while the R ggplot2 package (Wickham,
2009), as well as the density and qqnorm functions from the R stats
package (R Core Team, 2015) were used to plot the PEP score
distributions and investigate for normality. As non-normal PEP
score distributions were found, the non-parametric Kruskal–
Wallis analysis of variance test was chosen to investigate for
differences between the groups—using the kruskal.test function
from the R stats package, followed by post-hoc analysis with a two-
sided Dunn test (Dunn, 1964) with Bonferroni correction using
the dunnTest function from the R FSA package (Ogle, 2016).
6ftp://ftp.ensemblgenomes.org/pub/bacteria/current/fasta/bacteria_7_collection/
mycobacterium_smegmatis_str_mc2_155/cdna/
7http://bacteria.ensembl.org/Mycobacterium_smegmatis_str_mc2_155/Info/
Index
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FIGURE 1 | Bioinformatics workflow. A summary of the proteogenomic pipeline applied to obtain gene model validations, gene model modifications, novel ORF
annotations, and interrupted coding sequence identifications in M. smegmatis mc2155, using a translated genomic six frame database, a translated GeneMarkS gene
prediction database, and the Reference proteome.
Venn diagrams were produced using the online venn diagram
plotting tool Venny 2.1.0 (Oliveros, 2016).
RESULTS
From the 276,472 MS/MS spectra submitted to MaxQuant
at 1% FDR, 26,125 peptide sequences were identified from
172,570 spectra using the translated six frame database, 27,895
peptides from 176,518 spectra using the Reference proteome
database, and 27,735 peptides from 176,301 spectra using the
GeneMarkS database. Only protein groups were considered
where the leading protein had at least one unique peptide
identification. By mapping identified proteins from the different
databases to their correspondingORFs in the genome, 2887ORFs
were identified at the peptide level (identical translated ORF
sequences with multiple occurrences in the genome having been
combined into a single entry with multiple genomic coordinates
at the database generation phase; see Supplementary Table 1 and
Figure 2).
TSS Peptide Identifications
TSS peptide identifications can be divided into peptides with and
without N-Met cleavage. We identified 137 TSS peptides with
non-trypticMet N-termini at a genomic start codon position (of
which three were acetylated at the N-terminal), and 549 N-Met
cleaved peptides (of which 127were acetylated at theN-terminal).
The distribution of penultimate amino acids of identified N-Met
cleaved peptides—Thr (188), Ser (134), Ala (128), Pro (51), Gly
(18), Val (15), Asn (13), Leu (1), and Arg (1)—corresponds to the
non-random nature ofMet-AP cleavage (Link et al., 1997; Frottin
et al., 2006). Further, the identified start codon distribution
of all non-paralogous ORFs with an identified N-terminal—
ATG 63.96%, TTG 1.14%, and GTG 34.90%—corresponds to
the high percentage of GTG start codons reported previously
in M. tuberculosis (Cole et al., 1998) and M. smegmatis (Gallien
et al., 2009), but with a lower proportion of identified TTG start
codons. We identified three ORFs with evidence for multiple
initiation, corresponding to the observations of Kelkar et al.
(2011; see Supplementary Table 2).
Two ORFs were detected where the most upstream evidence
was an N-Met cleaved peptide and the penultimate position
corresponded to another possible start codon. For one of these
proteins, the second amino acid in the peptide was also a Met
located at an ATG codon, thus not allowing for discrimination
between N-Met cleavage and downstream initiation. For the
second protein, the N-terminal was identified by an N-Met
cleaved peptide with V as the penultimate amino acid, mapping
to a GTG codon at the annotated start site of a Reference
proteome sequence. Due to the known initiation of translation
with fMet, this was concluded to be an instance of N-Met
cleavage, leading to modification of the gene model to include
the adjacent upstream start codon.
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FIGURE 2 | Peptide and ORF identification venn diagrams. Panel (A)
compares peptide identifications from three different database searches. Panel
(B) shows the genomic open reading frames (ORFs) with at least one unique
peptide identified, from the different databases searches. Only peptides
identified in more than one replicate were considered. Two identified Reference
proteins spanning multiple ORFs (A4ZHT6 and A4ZHR8), not mapping on a
one to one basis to a genomic ORF, are included in the diagram as separate
ORFs.
Gene Model Validations
We identified 2810 genomic ORFs annotated to Reference
proteins with at least one unique peptide—with a median
of six unique peptides identified per ORF. Using N-terminal
peptide evidence, we validated the TSS for 558 Reference
protein gene models. The start codon distribution of validated
Reference protein TSSs also reflected the higher proportion
of GTG start codons in Mycobacteria—with 65.05% ATG,
0.72% TTG, and 34.23% GTG. Prominent Reference proteins
identified include A0R1H7_MYCS2—Fatty acid synthase—
with 168 unique peptides and 71.32% sequence coverage,
RPOC_MYCS2—DNA-directed RNA polymerase subunit
beta—with 96 unique peptides and 79.5% sequence coverage,
Q3L891_MYCS2—Linear gramicidin synthetase subunit D,
predicted protein—with 89 unique peptides and 54.98% sequence
coverage, Q3L885_MYCS2—Type I modular polyketide
synthase, predicted protein—with 88 unique peptides and
38.44% sequence coverage, and A0R617_MYCS2—Polyketide
synthase, predicted protein—with 82 unique peptides and 62.14%
sequence coverage. The predicted and unreviewed Reference
proteome entry A0R0A1_MYCS2 (Glyoxalase/bleomycin
resistance protein/dioxygenase) was identified with 99.28%
sequence coverage from 13 identified peptides and 152 MS/MS
spectra (see Figure 3 and Supplementary Table 3).
Gene model validation was also obtained for the Reference
protein MSHD_MYCS2 (Mycothiol acetyltransferase, inferred
from homology). This is an interrupted coding sequence (ICDS)
identified by Deshayes et al. (2007)—which they confirmed
by resequencing to span a sequencing error in the M.
smegmatismc2155 genome (GenBank accession DQ866865). We
present first-time peptide evidence for this protein with eight
peptides identified from 50 MS/MS scans using the Reference
proteome database, including a peptide spanning the frameshift
position (245) in the corrected sequence (see Figure 4 and
Supplementary Table 4).
Upstream Gene Model Modifications
Upstream peptide evidence was identified for 81 Reference
proteome gene models. Upstream peptide identifications can
be grouped into N-terminal (TSS) or fully tryptic upstream
peptides—for 39 of the upstream gene model modifications the
TSS was detected exactly, while for the 42 sequences with only
non-tryptic upstream peptides, the next upstream start-codon
in the sequence was located. The putative new gene models
thus obtained were searched against the NCBI nr database
using protein BLAST, to identify orthologous gene models,
or alternative gene models in the same strain. For 58 of the
modified gene models, nr BLAST alignment yielded a sequence
of the same length, supporting the gene model modification,
while 14 nr BLAST alignments in the group without exact TSS
identification indicated a TSS further upstream. Only one nr
BLAST result in the group with an identified TSS indicated
a further upstream TSS than the one identified. The start
codonGTGwas overrepresented in upstreamTSS identifications,
making up 38.46%—supporting the observation that ATG may
be over predicted as translational start codon (Gallien et al.,
2009). The median length of upstream N-terminal extension was
five amino acids in the group with upstream TSS identifications.
The Reference protein A0R4J1_MYCS2 (Phosphoribosylamine–
glycine ligase, inferred from homology) was identified with the
N-terminal of three identified peptides extending upstream of the
predicted TSS—extending the N-terminal of the protein by 29
amino acids. The modified sequence is identical to the predicted
protein I7GFT2_MYCS2 of the same strain (not included in the
Reference proteome; see Figure 5 and Supplementary Table 5).
Downstream Gene Model Modifications
Downstream TSS evidence was identified for 24 Reference
proteome gene models—with all cases corresponding to
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FIGURE 3 | Reference protein gene model validation —A0R0A1. A validation of the gene model of the Reference protein A0R0A1 (Glyoxalase/bleomycin
resistance protein/dioxygenase). This is an unreviewed predicted entry associated with dioxygenase activity (GO molecular function), of length of 138. Panel (A)
illustrates validation of the gene model at the peptide level visualized on the Ensembl genome browser, with a sequence coverage of 99.28% from 13 peptides and a
total of 152 MS/MS spectra identified in the Reference proteome database search. Panel (B) shows the identified translation start site (TSS) peptide, illustrating the
cleavage of initiator methionine (N-Met) by methionine aminopeptidase (MAP) with Val as the penultimate amino acid. Panel (C) shows a representative MS/MS
spectrum for the identified TSS peptide.
FIGURE 4 | Reference protein frameshift validation—MSHD. Shows the identification of A4ZHT6 (Mycothiol acetyltransferase), a Reference protein inferred from
homology. (A) This sequence corresponds to an interrupted coding sequence (ICDS) identified by Deshayes et al. (2007), which they confirmed by resequencing to
span a sequencing error in the M. smegmatis mc2155 genome (GenBank accession DQ866865). We present peptide evidence for this protein with eight peptides
identified from 50 MS/MS scans after searching the Reference proteome database, as well as identifying a peptide spanning the frameshift position (245) in the
corrected sequence—highlighted in red. (B) A representative spectrum of the highlighted peptide, which was identified with four MS/MS scans, supporting the
sequence correction at the peptide level.
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FIGURE 5 | Upstream gene model modification —A0R4J1. Shows evidence for gene model modification of the Reference protein A0R4J1
(Phosphoribosylamine–glycine ligase) by N-terminal extension, with the N-terminal of three identified peptides extending upstream of the predicted TSS, extending the
N-terminal of the protein by 29 amino acids. The modified sequence is identical to the predicted protein I7GFT2 for the same strain (not included in the Reference
proteome). Panel (A) shows the peptide RDPEVEGLAVAPGNAGTSSIADQYDVDVTSGEAVVK—highlighted in red—extending upstream of the annotated TSS along
with two other peptides. Panel (B) shows the sequence of the modified gene model of A0R4J1, with the annotated TSS position indicated by the blue arrow. Panel
(C) shows a representative MS/MS spectrum of RDPEVEGLAVAPGNAGTSSIADQYDVDVTSGEAVVK, identified from eight MS/MS spectra in the translated six frame
database search.
an alternative TSS prediction in the GeneMarkS database.
The predicted gene model A0QWY3_MYCS2 (Quinone
oxidoreductase) was shortened by 16 amino acids, with the
identification of a TSS peptide MHAIEVAETGGPEVLNYIER
PEPSPGPGEVLIK with a non-tryptic N-terminal downstream of
the annotated TSS. The downstream TSS peptide corresponded
to the N-terminal of the GeneMarkS predicted sequence for this
ORF, thus allowing this semi-tryptic TSS peptide to be included
in the GeneMarkS database search space. The modified sequence
is identical to I7G8G0_MYCS2, predicted for the same strain but
not included in the Reference proteome. The downstream TSS
peptide was identified from 34 MS/MS scans (see Figure 6 and
Supplementary Table 6).
Novel ORF Identifications
Due to the high prevalence of gene prediction errors, inclusion
in the UniProt Reference proteome was used as a benchmark
for annotation status in this study. Thus, all identified ORFs
not annotated to a Reference proteome entry were considered
novel identifications. Peptide evidence mapping to ORFs not
annotated to a Reference proteome entry was identified for 72
ORFs, of which 44 were identified with two or more peptides.
ORFs with one or more identified peptides that occurred
adjacent to another novel ORF identification, were examined as
possible evidence for Interrupted CoDing Sequences (ICDSs).
Nineteen novel ORFs that were identified with a single peptide,
and were supported by either protein BLAST alignment or a
previously identified transcript overlapping on the genome on
the same strand, are presented as lower ranking evidence for
genome annotation. Nine ORFs with only one identified peptide
and no supporting evidence, were excluded from the further
analysis due to the high likelihood of these identifications being
erroneous—leading to a total of 63 novel ORF identifications (see
Supplementary Table 7).
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FIGURE 6 | Downstream gene model modification —A0QWY3. Illustrates the downstream modification of an annotated predicted gene model A0QWY3 by 16
amino acids, with the identification of a TSS peptide MHAIEVAETGGPEVLNYIERPEPSPGPGEVLIK with a non-tryptic N-terminal downstream of the annotated TSS. In
this case, the downstream TSS peptide corresponded to the N-terminal of the GeneMarkS predicted sequence for this ORF, thus allowing this semi-tryptic TSS
peptide to be included in the GeneMarkS database search space. The modified sequence is identical to I7G8G0, predicted for the same strain but not included in the
Reference proteome. Panel (A) visualizes the identified peptides using the Ensembl genome browser, with the downstream TSS peptide highlighted in red. The
downstream gene model modification of A0QWY3 corresponds with the simultaneous upstream gene model modification of A0QWY4 on the opposite strand,
supporting both reannotations. Panel (B) illustrates the modified gene model, with the TSS peptide highlighted in red. Panel (C) illustrates a representative MS/MS
spectrum for the downstream TSS peptide, which was identified from 34 MS/MS scans using the GeneMarkS database search.
Validation of Previously Identification Interrupted
Coding Sequences (ICDSs)
Twelve non-Reference proteome ORFs identified at the
peptide level corresponded to six interrupted coding
sequences previously reported by Deshayes et al.
(2007), with GenBank accessions DQ866867, DQ866856,
DQ866859, DQ866863, DQ866858, and DQ866873—see
Supplementary Figures 1A–E,G, respectively, for Ensembl
genome browser visualizations, and Supplementary Table 8
rows 2–11 and 14–15 for detailed information. The above
authors had shown by resequencing that these frameshifts
corresponded to genome sequencing errors, and they also
reported peptide-level evidence for two of these sequences using
nano-LC/MS/MS analysis (DQ866873 and DQ866856). Thus, we
were able to identify four of these ICDSs with first-time peptide
evidence, and validate two ICDSs previously identified at the
peptide level.
Novel ICDSs
Four likely novel ICDS sequences were identified with peptide
evidence spanning either side of a possible genomic frameshift
region from eight non-Reference proteome ORFs. In an
interesting case, three novel peptides were identified from an
ORF with the closest nr protein BLAST alignment to a predicted
protein in Mycobacterium goodii—A0A0K0X632_9MYCO
(Peptidase M75). A non-Reference proteome predicted ORF
I7FS93_MYCS2 was identified partially overlapping and
upstream of this ORF with peptide evidence. This upstream
Frontiers in Microbiology | www.frontiersin.org 9 April 2016 | Volume 7 | Article 427
Potgieter et al. Proteogenomic Analysis of Mycobacterium smegmatis
ORF also aligned with high confidence to the same sequence
in M. goodii. To our knowledge an ICDS has not previously
been identified at this position, but peptide evidence from two
overlapping reading frames and alignment to an orthologous
sequence of a related species, supports the identification of
a novel ICDS at this site—although the existence of separate
adjacent protein coding genes cannot entirely be excluded (see
Supplementary Figures 1F and Supplementary Table 8 rows
12–13).
Another novel ORF with only one identified peptide—
TAILDAAAQLIAER—was identified upstream and partially
overlapping the predicted ORF I7G4B8_MYCS2 that was
identified with three peptides (see Supplementary Figure 1J
and Supplementary Table 8 rows 20–21). Both ORFs aligned
with high confidence to the predicted protein L8F9F0_MYCSM
of M. smegmatis MKD8—the genome sequence of which has
recently been announced (Gray et al., 2013). Thus, orthologous
sequence evidence combined with evidence at the peptide level
strongly supports the existence of an ICDS in this position, and
further investigation is needed to ascertain whether this is an
occurrence of authentic mutation or sequencing error, or in
fact two separate protein-coding genes. The identification of two
more ICDS sequences with peptide evidence on either side of a
possible frameshift position was also facilitated by alignment to
orthologous sequences submitted by Gray et al. (2013) as a result
of their genome sequencing efforts of M. smegmatis MKD8—
emphasizing the iterative nature of genome annotation as new
data becomes available (see Supplementary Figures 1H,I, and
Supplementary Table 8 rows 16–19).
Novel ORFs Identified with Two or More Peptides
We identified 44 non-Reference proteome ORFs with two or
more peptides (with a median of five identified unique peptides
per ORF in this group). Protein BLAST alignments were obtained
for 43 of these, and the gi accession numbers thus obtained
were mapped to their corresponding entries in UniProt using
the UniProt “Retrieve/ID mapping” tool8. Of the 39 sequences
that were mapped with this tool, 31 were predicted and eight
were inferred from homology. Three of these sequences were
annotated to M. smegmatis MKD8, one to M. thermoresistibile
strain ATCC 19527, and four to M. smegmatis non-specifically.
One identified ORF alignment—discussed above as part of an
identified ICDS—aligned to a sequence annotated to M. goodii.
The remaining 30 identified ORFs aligned to Non-Reference
proteome sequences from M. smegmatis mc2155—with 26
predicted and four inferred from homology. An interesting novel
ORF was identified with two peptides from eight MS/MS spectra
mapping to an intergenic region with a genomic position from
6,434,313 to 6,434,801 on the reverse strand. The sequence
yielded a protein nr BLAST alignment to G7CE94_MYCTH
(Lipoprotein LppV), a 182 amino acids long predicted protein
annotated toM. thermoresistibile, with an E-value of 2.13747e-44
(see Figure 7 and Supplementary Table 7).
8Retrieve/ID Mapping (UniProt). http://www.uniprot.org/uploadlists/
Database Comparison
The PEP scores of the identified peptides were obtained from
the MaxQuant peptides.txt file—which contains the identified
peptides with the PEP score calculated using the peptide length
and the Andromeda score for the best associated MS/MS
spectrum. Density plots of the distribution of PEP scores for
each database revealed non-gaussian PEP score distributions.
Analysis of variance of novel, annotated and reverse peptide PEP
scores for each database was performed using the Kruskal–Wallis
non-parametric analysis of variance test followed by post-hoc
analysis with a two-sided Dunn’s test and Bonferroni correction
(see Supplementary Data Sheet 5). A statistically significant
difference between group means (annotated, novel and reverse
peptides) for each of the three databases was found (p-values <
2.2e-16). Post-hoc analysis indicated a significant difference
between reverse and annotated peptide group PEP scores for
both the GeneMarkS (adjusted p-value 6.68e-21), six frame
database (adjusted p-value 3.67e-19), and Reference proteome
(adjusted p-value 1.05e-31) peptide results, while the assignment
of statistically significant differences between annotated and
novel peptide group PEP scores varied between the six frame
database (adjusted p-value 1.89e-06), and GeneMarkS database
(adjusted p-value 8.75e-01), although the values were much
higher than the annotated-reverse comparisons. Further, the
comparison between novel and reverse peptide group PEP scores
indicated a significant difference for both the six frame database
(adjusted p-value 9.84e-13) and GeneMarkS database (adjusted
p-value 5.50e-17) comparisons—with much lower adjusted p-
values than those of the annotated-novel group comparisons of
both databases. PEP score analysis was also performed on the
combined PSMs for each database obtained from the msms.txt
file, supporting the below analysis (see Supplementary Table 9,
Supplementary Figure 2, and Supplementary Data Sheet 6.
Reference Proteome Database
Using the Reference proteome database, 27,720 annotated
peptides were identified, with a median PEP score of 1.32E-04.
Further, 72 reverse hit peptides were reported by MaxQuant,
with a median PEP score of 7.46E-02. Kruskal–Wallis and Dunn’s
test post-hoc analysis showed a statistically significant difference
between the two groups (adjusted p-value 1.05e-31 before
excluding peptides seen in only one replicate). After selecting
peptides identified in at least two replicates, 2788 database
sequences were identified with at least one unique peptide.
For the group of Reference proteins with TSS validation and
single genomic coordinates, a start site distribution of ATG 353
(64.53%), TTG 4 (0.73%), andGTG 190 (34.73%)was determined
(see Figures 2, 8A, Table 1, and Supplementary Table 10).
GeneMarkS Database
The GeneMarkS database allowed for the identification of 27,168
annotated and 407 novel peptides, with a median peptide PEP
score of 1.16E-04 and 2.22E-04 respectively, and 59 reverse
hit peptides with a median peptide PEP score of 6.24E-02.
The PEP score distribution of annotated and novel peptides
were not significantly different using Kruskal–Wallis and post-
hoc tests (adjusted p-value 8.75e-01), and from the boxplot
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FIGURE 7 | Novel ORF identification. Panel (A) shows the identification of two peptides from eight MS/MS spectra mapping to an intergenic region in M.
smegmatis mc2155 from position 6,434,313 to 6,434,801 on the reverse strand. Panel (B) shows the identified sequence, extended up to the next upstream start
codon, with identified peptides in uppercase. The sequence yielded a protein nr BLAST alignment to G7CE94 (Lipoprotein LppV), a 182 amino acids long predicted
protein annotated to M. thermoresistibile, with an E-value of 2.13747e-44. Panel (C) shows a representative MS/MS spectrum identified with the translated six frame
database.
TABLE 1 | Database identifications.
Reference proteome Six frame database GeneMarkS database Combined
Reference protein ORF identifications 2788 2753 2773 2810
Reference TSS validations 554 282 439 558
All upstream gene model modifications 0 70 42 81
Upstream TSS identifications 0 29 28 39
Downstream TSS identifications 0 0 24 24
Novel ORF identifications 0 63 42 63
A table comparing Reference protein ORF identifications, TSS validations, upstream gene model modifications, upstream TSS identifications, downstream TSS identifications and novel
ORF identifications using three different databases.
visualizations appear similar to the PEP distribution of annotated
peptides obtained from the Reference proteome database. A
significant difference was found between annotated and reverse
peptide PEP score distributions (adjusted p-value 6.68e-21).
A comparison between novel and reverse peptide PEP score
distributions revealed a significant difference (adjusted p-value
5.50e-17), and the number of reverse hit peptides identified was
markedly lower than the number of novel peptides identified.
Thus, it is very likely that most novel identifications are true
positive identifications (see Figure 8B). After excluding peptides
only identified in a single sample, 2815 GeneMarkS sequences
were identified with at least one unique peptide. Of these, 42
were not annotated to a Reference protein. Further, in the
group of 558 Reference protein TSS validations, 442 sequences
had a corresponding entry in the GeneMarkS database with
the correct TSS prediction (of which 439 were identified)—
while only one did not have a corresponding entry, and 115
had a corresponding entry with an alternative TSS assignment.
Thus, in the group of TSS validations with a corresponding
GeneMarkS entry, GeneMarkS had correctly predicted the TSS
in 79.35% cases. Further in the set of all identified genomic
ORFs annotated to a Reference protein (2810), GeneMarkS had
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FIGURE 8 | Peptide PEP score distribution. The posterior error probability (PEP) score distribution of novel, annotated and reverse hit peptide identifications
obtained using three different database searches are shown, using the PEP score of the best PSM obtained for every peptide, from the MaxQuant peptides.txt output
file. (A) Reference proteome, (B) GeneMarkS database, (C) Six frame database. The whiskers represent 1.5 times the interquartile range (IQR) below and above the
first and third quartile, respectively. Differences in the means of the groups from each database search were evaluated using the non-parametric Kruskal–Wallis test,
which indicated significant differences between the means of novel and reverse peptide PEP scores in the GeneMarkS (adjusted p-value 5.50e-17) and six frame
database (adjusted p-value 9.84e-13). The p-values assigned to the comparisons between annotated and novel groups for the GeneMarkS (adjusted p-value
8.75e-01) and six frame (adjusted p-value 1.89e-06) databases were much larger than the p-values assigned to the comparisons between novel and reverse groups.
Significant differences were found in the annotated-reverse comparisons for all three databases—GeneMarkS (adjusted p-value 6.68e-21), six frame database
(adjusted p-value 3.67e-19) and Reference proteome (adjusted p-value1.050e-31). The effect of excluding peptides seen only in a single replicate on the PEP score
distributions is also apparent. The adjusted p-value assigned to the comparison between all six frame novel and annotated peptides (adjusted p-value 1.89e-06) was
much smaller than the adjusted p-value assigned to the same comparison after excluding peptides seen only in a single replicate (adjusted p-value 1.77e-02). In
contrast, the comparison between six frame novel and reverse peptides seen in at least two replicates was assigned an adjusted p-value of 2.87e-06, which is closer
to the p-value assigned to the comparison between annotated and reverse peptides seen in at least two replicates (adjusted p-value 6.09e-08; see
Supplementary Table 10 and Supplementary Data Sheet 5 for the results of Kruskal–Wallis tests and post-hoc pairwise comparisons).
predicted the ORF as protein-coding in 99.68% of cases. Of the
81 upstream gene model modifications, 80 had a corresponding
GeneMarkS sequence identified, of which 42 of the modifications
were supported by upstream peptide identifications from the
GeneMarkS database (with 28 TSS identifications). All of the 24
downstream gene model modifications were identified with TSS
evidence from the GeneMarkS database, with a mean N-terminal
shortening of ∼10 amino acids in this group (see Figure 2,
Table 1, and Supplementary Table 10).
Six Frame Database
The translated six frame database allowed for the identification of
25,427 annotated and 553 novel peptides, with a median peptide
PEP score of 1.07E-04 and 1.04E-03 respectively, and 48 reverse
hit peptides with amedian PEP score of 6.47E-02. Using Kruskal–
Wallis and Dunn’s test post-hoc analysis, a significant difference
between the group PEP scores of annotated and reverse (adjusted
p-value 3.67e-19), annotated and novel (adjusted p-value 1.89e-
06), and novel and reverse (adjusted p-value 9.84e-13) peptide
identifications was found. After selecting peptides seen in at least
two replicates, a much larger although still statistically significant
adjusted p-value of 1.77e-02 for the comparison between novel
and annotated groups was obtained—possibly indicating a
relatively higher proportion of false positive identifications in the
set of novel peptide identifications than in the annotated set. Post-
hoc comparison between novel and reverse peptide PEP score
distributions revealed adjusted p-values of 9.84e-13 and 2.87e-
06 before and after excluding peptides seen in only one replicate
respectively—much lower than the p-values obtained from the
comparison between novel and annotated peptide groups—
indicating a much greater difference between the distribution
of novel and reverse peptide PEP scores than between novel
and annotated peptides, see Figure 8C. After selecting peptides
seen in at least two replicates, 2825 ORFs were identified using
the six frame database. Seventy-two ORFs identified using the
six frame database mapped to non-Reference proteome ORFs.
Of the 558 Reference protein sequences with TSS validations, a
corresponding six frame sequence was identified in 544 cases.
In this group, 299—or 54.96%—of the six frame sequences
(translated from the most upstream start codon in the ORF)
correctly assigned the TSS. On average, the six frame database
overestimated the correct TSS by∼32 amino acids. Further, in the
group of 81 upstream gene model modifications, 80 cases had a
corresponding six frame sequence identified. In this group, 87.5%
of the upstream gene model modifications were supported by the
identification of upstream peptide evidence using the six frame
database. Of the 38 sequences with identified TSS sites in this
group, 29 were correctly assigned in the six frame database (see
Figure 2, Table 1, and SupplementaryTable 10).
DISCUSSION
Validation of genomic information by proteomic data has gained
momentum over the past few years. The improvement in genome
annotation can give rise to a better understanding of the
biology of pathogenic organisms and ultimately, new strategies
for disease prevention and treatment. Mass-spectrometry data
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has proven invaluable in terms of providing evidence of the
translation of genes expressed under differing conditions.
By mapping identified proteins from the different databases
to their corresponding ORFs in the genome, 2887 ORFs were
identified at the peptide level. We showed that the identified start
codon distribution of all identified ORFs with TSS identifications
corresponded to previously reported findings in Mycobacteria,
with a relatively higher percentage of GTG, although a relatively
lower proportion of TTG start codons was identified. The
identified penultimate amino acids of N-Met cleaved peptides
corresponded to previously published findings, although the
preponderance of Thr was notable.
We identified 2810 Reference proteins at the peptide level, and
using N-terminal peptide evidence we validated the TSS for 558
of these. Further, 81 gene model modifications were indicated by
the identification of peptides mapping upstream, and 24 by N-
terminal peptides mapping downstream, of the annotated TSS of
a Reference protein.
We provide experimental evidence for 63 novel ORFs not
previously verified at the protein level. A total of 44 ORFs were
identified with two or more peptides—of which 30 aligned to
predicted or inferred non-Reference proteome sequences of M.
smegmatismc2155. A single ORFwas identified with two peptides
but did not yield any protein BLAST alignments. Further, 19
novel ORFs were identified with a single peptide but were
supported by either protein BLAST alignment or a previously
identified transcript overlapping the ORF on the genome on
the same strand, and are presented as lower-ranking evidence
for annotation. We also identified six previously reported
interrupted coding sequences caused by sequencing errors, with
peptides identified on either side of a frameshift position—
four of which do not appear to have been previously identified
at the peptide level. Further, we identified evidence for four
novel ICDSs, three of which were supported by alignment to
orthologous sequence evidence from a newly sequenced strain
of M. smegmatis, emphasizing the importance of continuous
review of genome annotation as new information becomes
available.
In this study, we analyzed LC/MS/MS data with three
different sequence databases to improve the genome annotation
of M. smegmatis mc2155; two genomic—a six frame translation
and a GeneMarkS gene prediction database—and the UniProt
Reference proteome9. In both genomic databases, the PEP
score distribution of novel peptides was much closer to that
of annotated peptides than reverse sequence hits, and almost
identical in the GeneMarkS database—indicating that most
novel peptide identifications are likely to be true positive
identifications. A higher number of total peptide identifications
was attained using GeneMarkS than the six frame database—
closely approaching the number attained using the Reference
proteome. We report a high percentage of accurate TSS
predictions using GeneMarkS—79.35% in the group of Reference
protein TSS validations where a corresponding GeneMarkS
entry was predicted. This indicates that proteogenomic database
9Mycobacterium smegmatis Reference Proteome. UniProt Proteomes.
http://www.uniprot.org/proteomes/UP000000757 (Accessed August 9, 2015).
generation with targeted ORF and TSS predictions using de novo
gene prediction tools such as GeneMarkS can fruitfully decrease
the database search space, increasing the sensitivity of peptide
identifications. However, database compaction is a compromise
between reducing spurious possibilities, and minimizing the
exclusion of non-spurious entries from the search space. ORF and
TSS assignments will depend on the particular gene prediction
tool used, and will not be detected if incorrectly assigned at the
database generation phase. By including a six frame translation
database in the pipeline, ORFs missed by the gene prediction
algorithm, as well as upstream peptide evidence and TSS site
identifications not included in the gene prediction database, may
be identified.
Considering the PEP score distributions of novel and
annotated peptides, and the much smaller number of reverse
sequence hits than novel peptide identifications, it is evident
that the proteome of M. smegmatis mc2155 is not yet fully
characterized and more work needs to be done to identify novel
protein coding genes before a complete genome annotation status
is attained.We hope that the evidence we present here will lead to
the addition of new sequences to the Reference proteome of this
strain, supporting the downstream functional characterization
of these proteins, thus leading to a better understanding of
the biology of an important model organism of the infectious
M. tuberculosis. The gene model modifications we present for
many Reference proteome sequences—many of which have not
yet been identified at the protein level—facilitates improved
functional and structural characterization of these proteins,
allowing for accurate conclusions to be drawn by downstream
comparative proteomics analyses.
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Supplementary Figure 1 | Novel ORF ICDSs. Shows peptide evidence for six
previously identified ICDSs—of which only two have previously been reported at
the protein level—and four novel ICDS sequences. (A) DQ866867: A predicted
protein spanning a sequencing error reported by Deshayes et al. (2007), showing
peptides on either side of a frame shift position. (B) DQ866856: A protein
spanning a sequencing error reported by Deshayes et al. (2007), which they also
identified at the peptide level, showing peptides on either side of the frameshift
position. (C) DQ866859: Peptide evidence for a predicted protein spanning a
sequencing error reported by Deshayes et al. (2007). (D) DQ866863: Peptide
evidence for a predicted protein spanning a sequencing error reported by
Deshayes et al. (2007). (E) DQ866858: Peptide evidence for a predicted protein
spanning a sequencing error reported by Deshayes et al. (2007), showing an
upstream peptide identified in an overlapping ORF (highlighted in red). (F) Novel
ICDS: An upstream ORF first predicted by Deshayes et al. in 2007
(I7FS93_MYCS2), with downstream peptide evidence in an overlapping novel ORF
(three peptides). Both ORFs align to A0A0K0X632_9MYCO (peptidase M75 of M.
goodii), with very low E-values (0.0 and 5.03e-09, respectively). The downstream
peptides are highlighted in red. (G) DQ866873: an ICDS spanning a sequencing
error, and also detected at the protein level, reported by Deshayes et al. (2007).
Five upstream peptides in an overlapping novel ORF are highlighted in red. (H)
Novel ICDS: Two adjacent ORFs in alternate reading frames, both aligned to the
protein L8F5X0_MYCSM—predicted by Gray et al. (2013) from the genome of M.
smegmatis MKD8. (I) Novel ICDS: Two adjacent ORFs in alternate reading frames,
both aligned to the protein L8FGK0_MYCSM—predicted by Gray et al. (2013)
from the genome of M. smegmatis MKD8. (J) Novel ICDS: Two adjacent ORFs in
alternate reading frames, both aligned to the protein L8F9F0_MYCSM—predicted
by Gray et al. (2013) from the genome of M. smegmatis MKD8. A single upstream
peptide in an alternate frame is highlighted in red.
Supplementary Figure 2 | PSM PEP score distribution. Shows the PEP score
distributions of all annotated, novel and reverse sequence PSMs from the different
databases. The whiskers represent 1.5 times the interquartile range (IQR) below
and above the first and third quartile, respectively. In the GeneMarkS and six frame
database groups the PEP score distribution of novel PSMs is noticeably closer to
the group of annotated PSMs than reverse hits, indicating the high confidence of
novel PSM identifications. PEP score distributions are further improved by
excluding the PSMs of peptides that were only identified in a single replicate.
Using the Kruskal–Wallis test followed by post-hoc analysis, significant differences
were found for the comparisons between all novel and reverse PSM PEP scores
for both the GeneMarkS (adjusted p-value 2.20e-42) and six frame databases
(adjusted p-value 8.01e-36), respectively. Similarly, significant differences were
found between all annotated and all reverse group PSM PEP scores for the
Reference proteome (adjusted p-value 1.71e-70), GeneMarkS (adjusted p-value
2.00e-48) and six frame database (adjusted p-value 1.83e-44). The p-values
assigned to the comparisons between all annotated and all novel PSM PEP scores
were much higher for both the GeneMarkS (adjusted p-value 4.26e-02) and six
frame database (adjusted p-value 6.83e-09; see Supplementary Data Sheet 6)
for the results of Kruskal–Wallis tests and post-hoc pairwise comparisons.
Supplementary Table 1 | Combined ORF identifications.
Supplementary Table 2 | Multiple initiation.
Supplementary Table 3 | Validated TSSs.
Supplementary Table 4 | Frameshift validation.
Supplementary Table 5 | Upstream start annotations.
Supplementary Table 6 | Downstream start annotations.
Supplementary Table 7 | Novel ORF annotations.
Supplementary Table 8 | Novel ORF ICDSs.
Supplementary Table 9 | PSM PEP scores.
Supplementary Table 10 | Peptide PEP scores.
Data Sheet 1 | GeneMarkS sequence database (GFF format).
Data Sheet 2 | Six frame database peptide identifications (GFF format).
Data Sheet 3 | GeneMarkS database peptide identifications (GFF format).
Data Sheet 4 | Reference proteome peptide identifications (GFF format).
Data Sheet 5 | Analysis of best peptide PSM PEP scores.
Data Sheet 6 | Analysis of all peptide PSM PEP scores.
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